MENU
XBI
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS
SPDR® S&P Biotech ETF (XBI) Ownership - Who owns SPDR® S&P Biotech ETF?
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U... Show more
Category: #Health
Profile
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
Details
Group
Domestic Stock Funds
Category
Health
Net Assets
4751051300.00
Fund Existence
about 19 years
Turnover
90.00
Capitalization
N/A
Yield
0.17
Total Expense Ratio
0.35
Investment Style
N/A
Risk (Beta)
0.96
Fundamentals
XBI
Net Assets
4.75B
Yield
0.17
Fund Existence
about 19 years
Total Expense Ratio
0.35
Turnover
90.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.96
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.35
Assets in Top Ten Holdings
832M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
4.75B
Fund Type
ETF
Index Fund
Yes
Management Fee
0.35
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
142.00
Number of Net Holdings
142.00
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
26.42%
Gain YTD
-15.684
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com